Please use this identifier to cite or link to this item:
https://doi.org/10.1097/MOL.0b013e32835bcdff
DC Field | Value | |
---|---|---|
dc.title | Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: Review of recent findings | |
dc.contributor.author | Van Dam, R.M. | |
dc.contributor.author | Naidoo, N. | |
dc.contributor.author | Landberg, R. | |
dc.date.accessioned | 2014-11-26T02:13:34Z | |
dc.date.available | 2014-11-26T02:13:34Z | |
dc.date.issued | 2013-02 | |
dc.identifier.citation | Van Dam, R.M., Naidoo, N., Landberg, R. (2013-02). Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: Review of recent findings. Current Opinion in Lipidology 24 (1) : 25-33. ScholarBank@NUS Repository. https://doi.org/10.1097/MOL.0b013e32835bcdff | |
dc.identifier.issn | 09579672 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/108844 | |
dc.description.abstract | PURPOSE OF REVIEW: This review summarizes the results on flavonoid intakes and the development of type 2 diabetes and cardiovascular diseases. RECENT FINDINGS: Recent advances in food composition databases have allowed the evaluation of a more comprehensive range of flavonoids in epidemiological studies. In addition, the number of randomized trials of flavonoid-rich foods has increased rapidly. Results from both cohort studies and randomized trials suggest that anthocyanidins from berries and flavan-3-ols from green tea and cocoa may lower the risk of type 2 diabetes and cardiovascular diseases. Meta-analyses of randomized trials indicate that the strongest evidence exists for a beneficial effect of green tea on LDL-cholesterol and a beneficial effect of flavan-3-ol-rich cocoa on endothelial function and insulin sensitivity. Few randomized trials had a long duration or evaluated pure flavonoid compounds. SUMMARY: Evidence from cohort studies and randomized trials suggest beneficial effects of food sources of anthocyanidins (berries) and flavan-3-ols (green tea and cocoa) on cardiovascular health. These findings need to be confirmed in long-term randomized trials, and evaluation of pure compounds will be important to establish what specific flavonoids and doses are effective. © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1097/MOL.0b013e32835bcdff | |
dc.source | Scopus | |
dc.subject | anthocyanidins | |
dc.subject | catechins | |
dc.subject | flavan-3-ols | |
dc.subject | flavonoids | |
dc.subject | hesperidin | |
dc.type | Review | |
dc.contributor.department | SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH | |
dc.description.doi | 10.1097/MOL.0b013e32835bcdff | |
dc.description.sourcetitle | Current Opinion in Lipidology | |
dc.description.volume | 24 | |
dc.description.issue | 1 | |
dc.description.page | 25-33 | |
dc.description.coden | COPLE | |
dc.identifier.isiut | 000313550500005 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.